BCL3 Rekombinanter Antikörper
BCL3 Rekombinant Antikörper für IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
242233B11
Kat-Nr. : 84882-5-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84882-5-PBS bindet in IHC, IF/ICC, Indirect ELISA BCL3 und zeigt Reaktivität mit human, Maus
Getestete Reaktivität | human, Maus |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | BCL3 fusion protein Ag13375 |
Vollständiger Name | B-cell CLL/lymphoma 3 |
Berechnetes Molekulargewicht | 446 aa, 47 kDa |
Beobachtetes Molekulargewicht | 48-60 kDa |
GenBank-Zugangsnummer | BC064993 |
Gene symbol | BCL3 |
Gene ID (NCBI) | 602 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein A purfication |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
BCL3 (B-cell lymphoma 3 protein) has seven ankyrin repeat domains, a proline-rich N terminal domain and a serine- and proline-rich C-terminal domain (PMID: 31930327). BCL3 is an important contributor to chronic inflammatory disease states, such as osteoarthritis and rheumatoid arthritis (PMID: 12483727). BCL3 is a predominantly nuclear protein containing a trans-activation domain, and it can be recruited to NF-κB-responsive promoters, resulting in transcriptional activation or repression depending on the subunit composition of NF-κB complexes (PMID: 25089799, PMID: 30135206). BCL3 is known to be overexpressed in human breast cancers and is associated with reduced metastasis-free survival (PMID: 38255248).